There is no mention of 10 million dollars in revenue. I agree the outlook at the time wasn't good, but at 9.5 cents for the sp. I think a tough period has been factored in.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025